News & Updates

Show Multimedia Only

Genetic predisposition to higher BMI ups mortality risk in breast cancer survivors

20 Jan 2026

Nonmetastatic breast cancer survivors who are genetically predisposed to having an excess body weight appear to be at increased risk of mortality, as shown in a study.

Genetic predisposition to higher BMI ups mortality risk in breast cancer survivors

20 Jan 2026

Metformin prevents ACS-induced maternal hyperglycaemia, neonatal hypoglycaemia

20 Jan 2026 by

The use of metformin following antenatal corticosteroid (ACS), specifically betamethasone, significantly improves maternal glucose levels and lowers the risk of neonatal hypoglycaemia in preterm infants, according to a recent study.

Metformin prevents ACS-induced maternal hyperglycaemia, neonatal hypoglycaemia

20 Jan 2026

5-year data back omission of sentinel lymph node biopsy in early-stage breast cancer

19 Jan 2026 by

Sentinel lymph node biopsy (SLNB) may be safely omitted after breast-conserving therapy in patients with early-stage, node-negative breast cancer, with 5-year data from the BOOG 13-08 trial showing no difference in regional recurrence-free and distant disease-free survival outcomes whether or not SLNB was performed.

5-year data back omission of sentinel lymph node biopsy in early-stage breast cancer

19 Jan 2026

Melatonin may reduce delirium burden in children admitted to ICU

19 Jan 2026

The use of melatonin in paediatric intensive care unit (PICU) appears to lower the burden of positive delirium scores in children, a study has shown.

Melatonin may reduce delirium burden in children admitted to ICU

19 Jan 2026

Sacituzumab govitecan proves real-world survival benefits in metastatic breast cancer

19 Jan 2026 by

A real-world study of the antibody-drug conjugate (ADC) sacituzumab govitecan in patients with HR+/ HER2- metastatic breast cancer (mBC) or metastatic triple-negative breast cancer (mTNBC) shows consistent survival outcomes as those seen in clinical trials.

Sacituzumab govitecan proves real-world survival benefits in metastatic breast cancer

19 Jan 2026

PCSM model predicts long-term mortality risk from prostate cancer

19 Jan 2026

A recent study has shown the capacity of a novel prognostic model in predicting the long-term risk for prostate cancer-specific mortality (PCSM) following a prostate-specific antigen (PSA) test.

PCSM model predicts long-term mortality risk from prostate cancer

19 Jan 2026

Molecular analysis supports ibrutinib-venetoclax in poor-risk CLL patients

19 Jan 2026 by

Findings from the phase III NCRI* FLAIR** trial demonstrate the benefit of MRD***-guided ibrutinib + venetoclax (I+V) in chronic lymphocytic leukaemia (CLL) patients with gene aberrations compared with ibrutinib and fludarabine, cyclophosphamide, and rituximab (FCR).

Molecular analysis supports ibrutinib-venetoclax in poor-risk CLL patients

19 Jan 2026

Breastfeeding may be protective against depression, anxiety in mums

19 Jan 2026

Women who have ever breastfed appear to have reduced long-term risk of depression and anxiety, as suggested in a study.

Breastfeeding may be protective against depression, anxiety in mums

19 Jan 2026

Concentrated weekend workouts just as beneficial in hypertension

18 Jan 2026

Engaging in guideline-recommended moderate-to-vigorous physical activity for patients with hypertension helps reduce the risk of death, whether MVPA is distributed throughout the week or concentrated within 1–2 days during the weekend, as reported in a study.

Concentrated weekend workouts just as beneficial in hypertension

18 Jan 2026

No rise in breast cancer risk for young BRCA carriers on menopausal hormone therapy

18 Jan 2026 by

For young women with a pathogenic variant in BRCA1 or BRCA2, initiating hormone replacement therapy following surgical menopause does not appear to significantly increase the risk of breast cancer, with oestrogen-alone therapy even conferring protection, according to a study.

No rise in breast cancer risk for young BRCA carriers on menopausal hormone therapy

18 Jan 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Genetic predisposition to higher BMI ups mortality risk in breast cancer survivors

Genetic predisposition to higher BMI ups mortality risk in breast cancer survivors

Metformin prevents ACS-induced maternal hyperglycaemia, neonatal hypoglycaemia

Metformin prevents ACS-induced maternal hyperglycaemia, neonatal hypoglycaemia

5-year data back omission of sentinel lymph node biopsy in early-stage breast cancer

5-year data back omission of sentinel lymph node biopsy in early-stage breast cancer

Melatonin may reduce delirium burden in children admitted to ICU

Melatonin may reduce delirium burden in children admitted to ICU

Sacituzumab govitecan proves real-world survival benefits in metastatic breast cancer

Sacituzumab govitecan proves real-world survival benefits in metastatic breast cancer

PCSM model predicts long-term mortality risk from prostate cancer

PCSM model predicts long-term mortality risk from prostate cancer

Molecular analysis supports ibrutinib-venetoclax in poor-risk CLL patients

Molecular analysis supports ibrutinib-venetoclax in poor-risk CLL patients

Breastfeeding may be protective against depression, anxiety in mums

Breastfeeding may be protective against depression, anxiety in mums

Concentrated weekend workouts just as beneficial in hypertension

Concentrated weekend workouts just as beneficial in hypertension

No rise in breast cancer risk for young BRCA carriers on menopausal hormone therapy

No rise in breast cancer risk for young BRCA carriers on menopausal hormone therapy